Sun Pharmaceutical Industries Limited - Balance (Quarterly)

Sun Pharmaceutical Industries Limited
IN ˙ NSEI ˙ INE044A01036
1.618,50 ₹ ↓ -61,35 (-3,65%)
2026-04-24
DEL PRIS
Balance (Quarterly)

Sun Pharmaceutical Industries Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 72.836 45.082 53.611 46.237 72.220 105.207 90.150 102.688 122.574
Ændring (%) -38,10 18,92 -13,75 56,19 45,68 -14,31 13,91 19,37
Aktiver Nuværende 320.782 348.646 390.029 398.833 393.538 434.750 461.054 526.245 601.674
Ændring (%) 8,69 11,87 2,26 -1,33 10,47 6,05 14,14 14,33
Aktiver 690.544 698.078 744.555 807.436 794.412 854.996 881.157 921.006 1.037.065
Ændring (%) 1,09 6,66 8,45 -1,61 7,63 3,06 4,52 12,60
Forpligtelser 165.924 187.417 180.914 214.281 162.443 183.737 187.360 196.146 255.799
Ændring (%) 12,95 -3,47 18,44 -24,19 13,11 1,97 4,69 30,41
Egenkapital 524.620 510.661 563.641 593.155 631.969 671.259 693.796 724.860 781.266
Ændring (%) -2,66 10,37 5,24 6,54 6,22 3,36 4,48 7,78
Passiver og Aktiekapital 690.544 698.078 744.555 807.436 794.412 854.996 881.157 921.006 1.037.065
Ændring (%) 1,09 6,66 8,45 -1,61 7,63 3,06 4,52 12,60

Source: Capital IQ

Other Listings
IN:524715 1.733,80 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista